Meet The Science Team: Darin Dougherty M.D.

Meet The Science Team: Darin Dougherty M.D.

 min read
Neurable Team
If you intend to use this component with Finsweet's Table of Contents attributes follow these steps:
  1. Remove the current class from the content27_link item as Webflows native current state will automatically be applied.
  2. To add interactions which automatically expand and collapse sections in the table of contents select the content27_h-trigger element, add an element trigger and select Mouse click (tap)
  3. For the 1st click select the custom animation Content 27 table of contents [Expand] and for the 2nd click select the custom animation Content 27 table of contents [Collapse].
  4. In the Trigger Settings, deselect all checkboxes other than Desktop and above. This disables the interaction on tablet and below to prevent bugs when scrolling.

Dr. Darin D. Dougherty has seen a lot of brains. Not directly, of course, but rather through the use of neuroimaging technology–tools like fMRI and EEG that allow researchers to peek under the proverbial hood.

Director of the Division of Neurotherapeutics at Massachusetts General Hospital (MGH) and an Associate Professor at Harvard Medical School, Dougherty studies the biological basis of psychiatric disorders. This requires analyzing a lot of neural data. Yet, Dougherty doesn’t regularly measure his own brain activity, so it was somewhat of a departure when he came down to Neurable HQ to try out Enten.

An expert in neuroimaging, neurobiology, and psychopharmacology, Dougherty was well equipped to test drive our tech. He knew, for example, that if Enten was accurately measuring his brain activity, it should show an increase in alpha waves when he closed his eyes. After Enten passed this basic test, Dougherty tried something a bit more complicated.

“I put myself into a state of high focus and then low focus to see if Neurable’s algorithm output matched my expectations,” he says. “It did.”

Indeed, throughout the demo Enten detected Dougherty’s state of focus with a level of precision that, he says, is usually reserved for expensive lab equipment.

“Translating laboratory results into an everyday neurotech wearable is something I have rarely seen accomplished until I tried Enten myself,” he says. “It is easy to see how Enten could help consumers struggling to maintain attention.”

“It is easy to see how Enten could help consumers struggling to maintain attention.”

Following the demo, Dougherty reviewed Neurable’s white paper on the science behind Enten. Impressed, he noted that the research was “rigorous” and “beyond what would typically be expected for an early stage company.”

The author of over 100 peer-reviewed articles, Daughterty is no stranger to scientific rigor. He is currently the Medical Director of the Obsessive-Compulsive Disorder Institute at McLean Hospital and the Director of the Mood Disorders Section of MGH. In addition to holding these and other prominent roles, Dougherty has worked with numerous neurotechnology startups and has a keen sense of what it takes for a product to succeed in the industry. After meeting with the Neurable team and trying Enten, he notes that both inspire unique confidence.

“The team is aware of the great responsibility they hold to deliver a state-of-the-art consumer BCI,” he says. “I look forward to seeing how this technology can be used at a grander scale.”

Stay up to date

Sign up and receive the latest on features and releases.
By subscribing, you agree to our Privacy Policy and provide consent to receive updates from our company.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.